BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Appl...

November 27, 2023 | News

Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition

Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...

November 27, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

Porton Advanced and Ascle Therapeutics Form Strategic Partnership for NK Cell Applications in Cancer Prevention, Beauty, and Anti-aging

Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...

November 21, 2023 | News

Foundation Medicine Collaborates with Pierre Fabre on Non-Small Cell Lung Cancer Diagnostics

The companies will work collaboratively to seek the regulatory approval for Foundation Medicine assays which detect mutations including BRAFV600E to i...

November 16, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

November 14, 2023 | News

P&G's Gillette and Braun Join Forces with Movember to Tackle Men's Health Crisis in Australia

In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is...

November 13, 2023 | News

Guardant Health Introduces Shield Blood Test for Colorectal Cancer in South Korea

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...

November 13, 2023 | News

AdvanCell Doses First Patient in 212Pb-ADVC001 Clinical Trial for Metastatic Prostate Cancer in Australia

“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...

November 09, 2023 | News

Menarini Group and SciClone Pharma Partner to Bring ORSERDU® to China for Advanced Breast Cancer

ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations,...

November 08, 2023 | News

Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy

These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...

November 06, 2023 | News

XtalPi and CK Life Sciences Partner to Develop AI-Based Cancer Diagnostic Models

With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...

November 06, 2023 | News

Viseven CEO and Co-Founder Shares Her Breast Cancer Survivor Story

For the first time, Nataliya courageously shared her story of overcoming breast cancer, inspiring others with her inner power and resilience. Five years la...

October 31, 2023 | Opinion

GC Aesthetics and Bimini Health Tech Join Forces for Global Breast Reconstruction Solutions

This strategic collaboration combines GC Aesthetics' 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with...

October 27, 2023 | News

Stay Connected